Found: 2
Select item for more details and to access through your institution.
SIRT2 inhibitor SirReal2 enhances anti‐tumor effects of PI3K/mTOR inhibitor VS‐5584 on acute myeloid leukemia cells.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 18, p. 18901, doi. 10.1002/cam4.6480
- By:
- Publication type:
- Article
Real-world experience with venetoclax-based therapy for patients with myeloid sarcoma.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01068-z
- By:
- Publication type:
- Article